Ex vivo cetuximab exposure was found to increase activated basophil count in only one patient (Patient 1) who had a history of grade 3 allergy; CD203c‐positive cells (%) and ΔMFI (increase in median fluorescence intensity against negative control exposure) were 18.0% and 135, respectively (Fig. 2). The gene discussed is ENPP3; the disease is allergic disease.